Medtronic, Inc. (MDT) PT Lowered to $138 at Stifel Amid FDA Warning Letter
Tweet Send to a Friend
Stifel analyst Rick Wise lowered the price target on Medtronic, Inc. (NYSE: MDT) to $138.00 (from $140.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
